Skip to main content
. 2018 Oct 31;9(4):468–475. doi: 10.1016/j.jceh.2018.10.003

Table 2.

Cost Parameters for Assessing Cost-effectiveness of Sorafenib Versus BSC.

Parameter Type of cost Monthly cost INR (USD) 95% confidence interval
Distribution Source
Lower INR (USD) Upper INR (USD)
Sorafenib
Drug OOP 4730 (73.3) 4396 (68.1) 5064 (78.4) gamma Review of private chemist sources
Laboratory investigation HS 2757 (42.7) 2416 (37.4) 3098 (48.0) gamma 12, 18
Management of adverse effects
 Hand foot syndrome OOP 36 (0.6) 30 (0.5) 41 (0.6) gamma 21, 22
 Diarrhoea OOP 12 (0.2) 9 (0.1) 16 (0.2) gamma 21, 22, 23
 Hyper-tension OOP 50 (0.8) 24 (0.4) 77 (1.2) gamma 22, 23
 Rash OOP 231 (3.6) 113 (1.8) 349 (5.4) gamma Review of private chemist sources
 Nausea OOP 1.07 (0.02) 0.85 (0.01) 1.3 (0.02) gamma 22, 23
 Pain OOP 28 (0.4) 23 (0.5) 33 (0.5) gamma 21, 22
BSC
Laboratory investigation HS 884 (13.7) 857 (13.3) 910 (14.1) gamma 18
CECTa HS 2025 (31.4) 1567 (24.3) 2483 (38.5) gamma 18
CECTb HS 1350 (20.9) 1044 (16.2) 1656 (25.6) gamma 18
Management of complications
 Pain OOP 10,228 (158.4) 7774 (120.4) 12,682 (196.4) gamma Review of private chemist sources
 Nutritional protein OOP 1310 (20.2) 1094 (16.9) 1526 (23.6) gamma Review of private chemist sources
 Ascites OOP 6 (0.1) 5 (0.1) 7 (0.1) gamma 22
 UGIE varices OOP 11 (0.2) 3 (0.1) 18 (0.3) gamma 22, 23
 Nausea OOP 1.07 (0.02) 0.85 (0.01) 1.3 (0.02) gamma 22, 23
 Jaundice OOP 544 (8.4) 387 (5.9) 702 (10.8) gamma 22, 23
Per outpatient consultation HS 259 (4.0) 109 (1.7) 408 (6.3) gamma 33
Per patient bed days General Ward OOP 2219 (34.4) 870 (13.5) 3569 (55.3) gamma 12, 33
Per patient bed days ICU OOP 12,801 (198.3) 12,597 (195.1) 13,005 (201.4) gamma 12, 24

1 USD = INR 64.56.

INR: Indian national rupee, USD: US dollar, OOP: out of pocket, HS: health system, BSC: best supporting care, ICU: intensive care unit, CECT: contrast enhanced computed tomography, UGIE: upper gastrointestinal endoscopy.

a

10% of patients requiring CECT.

b

20% of patients requiring CECT.